IMDX
IMDX clinical trials: Insight Molecular Diagnostics Inc.
Every trial on ClinicalTrials.gov where Insight Molecular Diagnostics Inc. is the lead sponsor or a listed collaborator, the trials it leads first, each labelled Lead or Collaborator. Phase, status and dates as registered.
- 3
- Trials linked
- 3
- As lead sponsor
- 0
- As collaborator
- 0
- Primary completions as lead sponsor, next 90 days
IMDX on the catalyst calendar · IMDX registry changes
| Primary completion | Trial | Company and role | Phase | Status | Enrollment | Interventions | Completion |
|---|---|---|---|---|---|---|---|
| Dec 2032Sponsor estimate | NCT07551531GraftAssure Lowering Allograft rejeCTIon by Combination- (GALACTIC) TrialInsight Molecular Diagnostics · Kidney Transplant | IMDXLead | No phase registered | Not yet recruiting | Locked | Locked | Locked |
| Nov 30, 2025Sponsor estimate | NCT07060716Validation of Donor-Derived Cell-Free DNA (Dd-cfDNA) for Kidney Transplant MonitoringInsight Molecular Diagnostics · Kidney Transplant Rejection | IMDXLead | No phase registered | Recruiting | Locked | Locked | Locked |
| Oct 28, 2022Actual | NCT05032352Predictive Assay for Decision Making in Adjuvant TherapyInsight Molecular Diagnostics · Carcinoma, Non-Small-Cell Lung | IMDXLead | No phase registered | Terminated | Locked | Locked | Locked |
- Primary completion Dec 2032Sponsor estimateNo phase registeredNCT07551531GraftAssure Lowering Allograft rejeCTIon by Combination- (GALACTIC) TrialInsight Molecular Diagnostics · Kidney TransplantNot yet recruitingIMDXLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Nov 30, 2025Sponsor estimateNo phase registeredNCT07060716Validation of Donor-Derived Cell-Free DNA (Dd-cfDNA) for Kidney Transplant MonitoringInsight Molecular Diagnostics · Kidney Transplant RejectionRecruitingIMDXLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Oct 28, 2022ActualNo phase registeredNCT05032352Predictive Assay for Decision Making in Adjuvant TherapyInsight Molecular Diagnostics · Carcinoma, Non-Small-Cell LungTerminatedIMDXLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
Enrollment, interventions and the start and completion dates are locked on 3 rows here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.
Unlock with TrialScanner